502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer. - Bakouny, Z.; Grover, P.; Labaki, C.; Awosika, J.; Gulati, S.; Hsu, C-Y.; Bilen, M.A.; Eton, O.; Fecher, L.; Hwang, C.; Khan, H.; McKay, R.R.; et al. (Annals of Oncology, 2022)